Results 1 to 10 of about 8,197 (178)

RNF213 Variants Associated With Periventricular Anastomosis Regression After Revascularization in Moyamoya Disease. [PDF]

CNS Neurosci Ther
Bao et al. demonstrated that RNF213 variants in the C‐terminal region are associated with periventricular anastomosis (PA) regression, underscoring a broader genotype and angiographic phenotype correlation. Furthermore, PA regression could serve as a potential radiological marker for predicting the risk of future hemorrhage in moyamoya disease patients.
Bao Y, Zeng C, Xue Y, Zhao Q, Sun X, Meng F, Chen H, Cui Y, Yuan Q, Li H, Zhang D, Wang R, Zhang Y, Zhao J, Zhang Q.   +14 more
europepmc   +2 more sources

Hyperkinetic Movement Disorder as the First Manifestation of Moyamoya Disease in a 15-Year-Old: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Physicians evaluating pediatric movement disorders, especially chorea, should consider a broad differential diagnosis, including vascular etiologies such as moyamoya disease. Prompt recognition, appropriate neuroimaging, and early diagnosis are crucial for guiding management and optimizing patient outcomes.
Okar L, Gowda R, Alzoubi H, Narayanan K, Wallace M.   +4 more
europepmc   +2 more sources

Optimal Surgical Timing and Outcome Prediction in Hemorrhagic Moyamoya Disease: A Retrospective Cohort Study. [PDF]

CNS Neurosci Ther
This cohort study developed and validated the first prognostic nomogram for hemorrhagic MMD, incorporating five independent predictors including a defined optimal surgical window of 3 to 6 months. The model demonstrated good discrimination and aids in risk stratification for clinical monitoring.
Guo Q, Xie M, Zou Z, Wang QN, Han C, Bao X, Duan L.   +6 more
europepmc   +2 more sources

Chemotherapy management of a pediatric B-ALL patient with moyamoya disease: a case report [PDF]

Frontiers in Oncology
Moyamoya disease is a rare, chronic cerebrovascular disorder characterized by progressive stenosis or occlusion of the terminal portions of the internal carotid arteries and the subsequent development of abnormal compensatory vascular networks.
Yi-ren Cheng, Juan Han, Zi-yi Huang, Ping Qu, Fen Zhou   +4 more
doaj   +2 more sources

Moyamoya disease [PDF]

QJM, 2016
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease characterized by progressive stenosis at the terminal portion of the internal carotid artery and an abnormal vascular network at the base of the brain. Although its etiology is unknown, recent genetic studies have identified RNF213 in the 17q25-ter region as an important ...
M, Tahir, U, Khan
  +9 more sources

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease

Frontiers in Neurology, 2021
Objective: To determine if elevated rates of autoimmune disease are present in children with both Down syndrome and moyamoya disease given the high rates of autoimmune disease reported in both conditions and unknown etiology of angiopathy in this ...
Jonathan D. Santoro, Jonathan D. Santoro, Sarah Lee, Anthony C. Wang, Eugenia Ho, Eugenia Ho, Deepti Nagesh, Deepti Nagesh, Mellad Khoshnood, Runi Tanna, Ramon A. Durazo-Arvizu, Melanie A. Manning, Melanie A. Manning, Brian G. Skotko, Brian G. Skotko, Gary K. Steinberg, Michael S. Rafii, Michael S. Rafii   +17 more
doaj   +1 more source

Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version

Neurologia Medico-Chirurgica, 2022
In this report, we, the Research Committee on Moyamoya Disease (Spontaneous Occlusion of the circle of Willis), describe in detail the changes in the new “Diagnostic Criteria 2021” for moyamoya disease and its scientific basis to make it widely known to ...
Satoshi KURODA, Miki FUJIMURA, Jun TAKAHASHI, Hiroharu KATAOKA, Kuniaki OGASAWARA, Toru IWAMA, Teiji TOMINAGA, Susumu MIYAMOTO, The Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor, and Welfare, Japan   +8 more
doaj   +1 more source

Clinical value of the systemic immune-inflammation index in moyamoya disease

Frontiers in Neurology, 2023
BackgroundMoyamoya disease (MMD) is a rare cerebrovascular disorder with unknown etiology. The underlying pathophysiological mechanism of moyamoya disease remains to be elucidated, but recent studies have increasingly highlighted that abnormal immune ...
Erheng Liu, Erheng Liu, Chengyuan Liu, Chengyuan Liu, Lide Jin, Hu Zhou, Xueyi Tan, Xueyi Tan, Guibo Zhang, Guibo Zhang, Weihua Tao, Xiang Gao, Heng Zhao, Chao Luo, Xuehua Li, Shuaifeng Yang   +15 more
doaj   +1 more source

Moyamoya Disease [PDF]

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2000
Moyamoya disease is a specific chronic cerebrovascular occlusive disease first reported by Japanese surgeons in 1957. The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion. It may cause ischemic attacks or cerebral
I, Fleetwood, G K, Steinberg
openaire   +4 more sources

Research progress of moyamoya disease combined with renovascular hypertension

Frontiers in Surgery, 2022
Moyamoya disease (MMD) is an idiopathic cerebrovascular disease which was first described by Suzuki and Takaku in 1969. Moyamoya disease is a non-atherosclerotic cerebrovascular structural disorder.
Erheng Liu, Erheng Liu, Heng Zhao, Chengyuan Liu, Chengyuan Liu, Xueyi Tan, Xueyi Tan, Chao Luo, Chao Luo, Shuaifeng Yang   +9 more
doaj   +1 more source